Log In
BCIQ
Print this Print this
 

FYU-981

  Manage Alerts
Collapse Summary General Information
Company Fuji Yakuhin Co. Ltd.
DescriptionNot disclosed.
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHyperuricemia / gout
Indication DetailsTreat hyperuricemia in patients with or without gout
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today